BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30525753)

  • 1. Valchlor maintenance therapy for patients with mycosis fungoides who received low dose total skin electron beam treatment.
    Jennings T; Duffy R; Gochoco A; Knoblauch K; Shi W; Alpdogan SO; Porcu P; Werner-Wasik M; Sahu J
    Chin Clin Oncol; 2019 Feb; 8(1):13. PubMed ID: 30525753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
    Chinn DM; Chow S; Kim YH; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides).
    Quirós PA; Jones GW; Kacinski BM; Braverman IM; Heald PW; Edelson RL; Wilson LD
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1027-35. PubMed ID: 9276369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials.
    Hoppe RT; Harrison C; Tavallaee M; Bashey S; Sundram U; Li S; Million L; Dabaja B; Gangar P; Duvic M; Kim YH
    J Am Acad Dermatol; 2015 Feb; 72(2):286-92. PubMed ID: 25476993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total Skin Electron Beam Therapy for Mycosis Fungoides Revisited With Adjuvant Systemic Therapy.
    Rivers CI; Singh AK
    Clin Lymphoma Myeloma Leuk; 2019 Feb; 19(2):83-88. PubMed ID: 30528417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective cohort study of condensed low-dose total skin electron beam therapy for mycosis fungoides: Reduction of disease burden and improvement in quality of life.
    Song A; Gochoco A; Zhan T; Sahu J; Alpdogan O; Porcu P; Nikbakht N; Shi W
    J Am Acad Dermatol; 2020 Jul; 83(1):78-85. PubMed ID: 32004646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to Chlormethine/Mechlorethamine gel Maintenance Treatment Regimen in Patients With Mycosis Fungoides: A Single-center Retrospective Study.
    Correia E; Krishnasamy S; Suriano JG; Shi W; Alpdogan SO; Sahu J; Porcu P; Nikbakht N
    Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):581-588. PubMed ID: 35393251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose total skin electron beam therapy: Quality of life improvement and clinical impact of maintenance and adjuvant treatment in patients with mycosis fungoides or Sezary syndrome.
    Elsayad K; Kroeger K; Greve B; Moustakis C; Assaf C; Stadler R; Lenz G; Weishaupt C; Eich HT
    Strahlenther Onkol; 2020 Jan; 196(1):77-84. PubMed ID: 31591658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation).
    Ysebaert L; Truc G; Dalac S; Lambert D; Petrella T; Barillot I; Naudy S; Horiot JC; Maingon P
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1128-34. PubMed ID: 15001254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total skin electron beam therapy in mycosis fungoides-a shift towards lower dose?
    Chowdhary M; Song A; Zaorsky NG; Shi W
    Chin Clin Oncol; 2019 Feb; 8(1):9. PubMed ID: 30525748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides.
    Navi D; Riaz N; Levin YS; Sullivan NC; Kim YH; Hoppe RT
    Arch Dermatol; 2011 May; 147(5):561-7. PubMed ID: 21576575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose (10-Gy) total skin electron beam therapy for cutaneous T-cell lymphoma: an open clinical study and pooled data analysis.
    Kamstrup MR; Gniadecki R; Iversen L; Skov L; Petersen PM; Loft A; Specht L
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):138-43. PubMed ID: 25863761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient perspectives regarding the value of total skin electron beam therapy for cutaneous T-cell lymphoma/mycosis fungoides: a pilot study.
    Yu JB; Khan AM; Jones GW; Reavely MM; Wilson LD
    Am J Clin Oncol; 2009 Apr; 32(2):142-4. PubMed ID: 19307950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose total skin electron beam therapy plus oral bexarotene maintenance therapy for cutaneous T-cell lymphoma.
    Elsayad K; Rolf D; Sunderkötter C; Weishaupt C; Müller EC; Nawar T; Stranzenbach R; Livingstone E; Stadler R; Steinbrink K; Moritz RKC; Eich HT
    J Dtsch Dermatol Ges; 2022 Mar; 20(3):279-285. PubMed ID: 34984837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides.
    An Y; Jiang W; Andraos TY; Reddy JP; Yehia ZA; Lloyd S; Duvic M; D'Souza NM; Milgrom SA; Pinnix CC; Oki Y; Smith GL; Wilson LD; Dabaja BS
    Radiother Oncol; 2019 Feb; 131():88-92. PubMed ID: 30773193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total Skin Electron Beam Therapy in the Treatment of Mycosis Fungoides: A Review of Conventional and Low-Dose Regimens.
    Chowdhary M; Chhabra AM; Kharod S; Marwaha G
    Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):662-671. PubMed ID: 27692530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy.
    Wilson LD; Licata AL; Braverman IM; Edelson RL; Heald PW; Feldman AM; Kacinski BM
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):987-95. PubMed ID: 7607973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.
    Talpur R; Venkatarajan S; Duvic M
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):591-7. PubMed ID: 25068889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing Care and Compliance for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma With Mechlorethamine Gel.
    Benjamin Chase A; Markel K; Tawa MC
    Clin J Oncol Nurs; 2015 Dec; 19(6):E131-9. PubMed ID: 26583648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.